Literature DB >> 29777696

Sterilized bifidobacteria suppressed fat accumulation and blood glucose level.

Keita Kikuchi1, Mahmoud Ben Othman1, Kazuichi Sakamoto2.   

Abstract

Probiotics such as Lactobacillus and Bifidobacterium improve the balance of intestinal microflora and have various physiological functions beneficial to human health. It is not always known whether the ingested microbial cells are viable- or killed. However, even sterilized bacterial cells are functional. Bacterial cell functions are strain-specific and their modes of action are still poorly understood. The aim of this study was to elucidate the roles of sterilized bifidobacteria in obesity and lipid metabolism. To this end, mice were orally ingested sterilized bacteria. Male C57BL/6J mice aged 7 wks were raised on a high-fat diet and received oral sterilized bifidobacteria for 4 wks. Although the amount of food they ingested did not change in response to bifidobacteria administration, both weight gain and epididymal body fat mass were significantly reduced. In addition, the elevated blood glucose, triglyceride, and total cholesterol levels observed in the mice on the high-fat diet all decreased in response to bifidobacteria treatment. Hepatic triglyceride levels also decreased. Furthermore, oral glucose tolerance and insulin resistance tests indicated that sterilized bifidobacteria improved glucose tolerance and diminished insulin resistance. Sterilized bifidobacteria also decreased blood lipopolysaccharides and altered intestinal flora. The present study indicates that in mice on a high-fat diet, sterilized bifidobacteria suppressed fat accumulation, improved insulin resistance, and lowered blood glucose levels.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blood glucose; Fat accumulation; Probiotics; Serum cholesterol; Sterilized bifidobacteria

Mesh:

Substances:

Year:  2018        PMID: 29777696     DOI: 10.1016/j.bbrc.2018.05.105

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  The Promising Role of Microbiome Therapy on Biomarkers of Inflammation and Oxidative Stress in Type 2 Diabetes: A Systematic and Narrative Review.

Authors:  Pradipta Paul; Ridhima Kaul; Basma Abdellatif; Maryam Arabi; Rohit Upadhyay; Reya Saliba; Majda Sebah; Ali Chaari
Journal:  Front Nutr       Date:  2022-05-25

2.  Maternal gut microbiota Bifidobacterium promotes placental morphogenesis, nutrient transport and fetal growth in mice.

Authors:  Jorge Lopez-Tello; Zoe Schofield; Amanda N Sferruzzi-Perri; Lindsay J Hall; Raymond Kiu; Matthew J Dalby; Douwe van Sinderen; Gwénaëlle Le Gall
Journal:  Cell Mol Life Sci       Date:  2022-06-28       Impact factor: 9.207

Review 3.  Trends in insulin resistance: insights into mechanisms and therapeutic strategy.

Authors:  Mengwei Li; Xiaowei Chi; Ying Wang; Sarra Setrerrahmane; Wenwei Xie; Hanmei Xu
Journal:  Signal Transduct Target Ther       Date:  2022-07-06

4.  New insights on strain-specific impacts of probiotics on insulin resistance: evidence from animal study.

Authors:  Nazarii Kobyliak; Tetyana Falalyeyeva; Olena Tsyryuk; Majid Eslami; Dmytro Kyriienko; Tetyana Beregova; Liudmila Ostapchenko
Journal:  J Diabetes Metab Disord       Date:  2020-02-16

5.  Effect of the combined action of Quercus cortex extract and probiotic substances on the immunity and productivity of broiler chickens.

Authors:  G K Duskaev; S G Rakhmatullin; N M Kazachkova; Y V Sheida; I N Mikolaychik; L A Morozova; B H Galiev
Journal:  Vet World       Date:  2018-10-13

Review 6.  Mitophagy in Hepatic Insulin Resistance: Therapeutic Potential and Concerns.

Authors:  Zuqing Su; Yutong Nie; Xiufang Huang; Ying Zhu; Bing Feng; Lipeng Tang; Guangjuan Zheng
Journal:  Front Pharmacol       Date:  2019-10-10       Impact factor: 5.810

Review 7.  NLR and Intestinal Dysbiosis-Associated Inflammatory Illness: Drivers or Dampers?

Authors:  Jefferson Elias-Oliveira; Jefferson Antônio Leite; Ítalo Sousa Pereira; Jhefferson Barbosa Guimarães; Gabriel Martins da Costa Manso; João Santana Silva; Rita Cássia Tostes; Daniela Carlos
Journal:  Front Immunol       Date:  2020-08-11       Impact factor: 7.561

Review 8.  Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions.

Authors:  Shireen Mohammad; Christoph Thiemermann
Journal:  Front Immunol       Date:  2021-01-11       Impact factor: 7.561

9.  The Fecal Microbiota Is Already Altered in Normoglycemic Individuals Who Go on to Have Type 2 Diabetes.

Authors:  Li Wang; Xinwen Yu; Xiaoqiang Xu; Jie Ming; Zhifeng Wang; Bin Gao; Ying Xing; Jie Zhou; Jianfang Fu; Tao Liu; Xiangyang Liu; Malgorzata A Garstka; Xiaokai Wang; Qiuhe Ji
Journal:  Front Cell Infect Microbiol       Date:  2021-02-18       Impact factor: 5.293

Review 10.  Regulation of Gut Microbiota and Metabolic Endotoxemia with Dietary Factors.

Authors:  Nobuo Fuke; Naoto Nagata; Hiroyuki Suganuma; Tsuguhito Ota
Journal:  Nutrients       Date:  2019-09-23       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.